Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
As the telehealth industry has grown, Hers has followed suit. It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide ...
The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results